|
Outcome |
Odds Ratio (95% CI) |
|---|---|
|
Benefits |
|
|
Myocardial Infarction |
0.72 (0.60 to 0.87) |
|
Coronary Heart Disease Death |
0.87 (0.70 to 1.09) |
|
Total Stroke |
1.02 (0.85 to 1.23) |
|
All-Cause Mortality |
0.93 (0.84 to 1.02) |
|
Harms |
|
|
Hemorrhagic Stroke* |
1.4 (0.9 to 2.0) |
|
Major Gastrointestinal Bleed* |
1.7 (1.4 to 2.1) |
*Source: Sudlow C. Antithrombotic treatment. Clinical Evidence, 5th ed. London: BMJ Publishing Group; 2001.